Literature DB >> 11819806

The prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancer.

C X Zheng1, W H Zhan, J Z Zhao, D Zheng, D P Wang, Y L He, Z Q Zheng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11819806      PMCID： PMC4688738          DOI： 10.3748/wjg.v7.i3.431

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  40 in total

1.  Sequence analysis of carcinoembryonic antigen: identification of glycosylation sites and homology with the immunoglobulin supergene family.

Authors:  R J Paxton; G Mooser; H Pande; T D Lee; J E Shively
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

2.  Metastatic potential of human colorectal carcinomas implanted into nude mice: prediction of clinical outcome in patients operated upon for cure.

Authors:  J M Jessup; R Giavazzi; D Campbell; K R Cleary; K Morikawa; R Hostetter; E N Atkinson; I J Fidler
Journal:  Cancer Res       Date:  1989-12-15       Impact factor: 12.701

3.  Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A.

Authors:  A Takada; K Ohmori; N Takahashi; K Tsuyuoka; A Yago; K Zenita; A Hasegawa; R Kannagi
Journal:  Biochem Biophys Res Commun       Date:  1991-09-16       Impact factor: 3.575

4.  Immunohistochemical expression of carbohydrate antigen 19-9 in colorectal carcinoma.

Authors:  R Shimono; M Mori; K Akazawa; Y Adachi; K Sgimachi
Journal:  Am J Gastroenterol       Date:  1994-01       Impact factor: 10.864

5.  Carcinoembryonic antigen and carbohydrate antigen 19-9 levels of peripheral and draining venous blood in colorectal cancer patients. Correlation with histopathologic and immunohistochemical variables.

Authors:  Y Tabuchi; H Deguchi; Y Saitoh
Journal:  Cancer       Date:  1988-10-15       Impact factor: 6.860

6.  Value of endoscopic ultrasonography for assessment of patients presenting elevated tumor marker levels after surgery for colorectal cancers.

Authors:  M Giovannini; D Bernardini; J F Seitz; V Moutardier; G Hoevenaeghel; G Monges; J R Delpero
Journal:  Endoscopy       Date:  1998-06       Impact factor: 10.093

7.  The clinicopathologic features of serum CA 19-9-positive colorectal cancers.

Authors:  T Ueda; E Shimada; T Urakawa
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

8.  CA72-4 compared with carcinoembryonic antigen as a tumour marker for gastric cancer.

Authors:  R Hamazoe; M Maeta; T Matsui; S Shibata; S Shiota; N Kaibara
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

9.  Significance of CA 72-4 in colorectal carcinoma. Comparison with CEA and CA 19-9.

Authors:  L Fernández-Fernández; E Tejero; A Tieso
Journal:  Eur J Surg Oncol       Date:  1995-08       Impact factor: 4.424

10.  Prospective monitoring trial for carcinoma of colon and rectum after surgical resection.

Authors:  H J Wanebo; M Llaneras; T Martin; D Kaiser
Journal:  Surg Gynecol Obstet       Date:  1989-12
View more
  24 in total

1.  Expression and bioactivity identification of soluble MG7 scFv.

Authors:  Zhao-Cai Yu; Jie Ding; Bo-Rong Pan; Dai-Ming Fan; Xue-Yong Zhang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

2.  Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA.

Authors:  Xing-Lei Qin; Zhuo-Ren Wang; Jing-Sen Shi; Min Lu; Lin Wang; Quan-Ru He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

3.  Feasibility of CYFRA 21-1 as a serum biomarker for the detection of colorectal adenoma and advanced colorectal adenoma in people over the age of 45.

Authors:  Do Hyoung Lim; Jai Hyuen Lee; Jong Wan Kim
Journal:  J Clin Lab Anal       Date:  2017-02-10       Impact factor: 2.352

4.  Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.

Authors:  Shi-Yan Zhang; Min Lin; Hui-Bing Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

5.  Are high initial CEA and CA 19-9 levels associated with the presence of K-ras mutation in patients with metastatic colorectal cancer?

Authors:  Fatih Selcukbiricik; Ahmet Bilici; Deniz Tural; Sibel Erdamar; Ozlem Soyluk; Evin Buyukunal; Fuat Demirelli; Suheyla Serdengecti
Journal:  Tumour Biol       Date:  2013-04-28

6.  Clinical Usefulness of Serum CYFRA 21-1 in Patients with Colorectal Cancer.

Authors:  Jai Hyuen Lee
Journal:  Nucl Med Mol Imaging       Date:  2013-08-06

7.  Screening and identification of mimotope of gastric cancer associated antigen MGb1-Ag.

Authors:  Zhe-Yi Han; Kai-Chun Wu; Feng-Tian He; Quan-Li Han; Yong-Zhan Nie; Ying Han; Xiao-Nan Liu; Jian-Yong Zheng; Mei-Hong Xu; Tao Lin; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

8.  Transforming growth factor-beta1 in invasion and metastasis in colorectal cancer.

Authors:  Bin Xiong; Hong-Yin Yuan; Ming-Bo Hu; Feng Zhang; Zheng-Zhuan Wei; Ling-Ling Gong; Guo-Liang Yang
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

9.  Arterial chemotherapy of 5-fluorouracil and mitomycin C in the treatment of liver metastases of colorectal cancer.

Authors:  Lian-Xin Liu; Wei-Hui Zhang; Hong-Chi Jiang; An-Long Zhu; Lin-Feng Wu; Shu-Yi Qi; Da-Xun Piao
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

10.  Association of serum levels of CEA, CA199, CA125, CYFRA21-1 and CA72-4 and disease characteristics in colorectal cancer.

Authors:  Wa Zhong; Zhong Yu; Jun Zhan; Tao Yu; Ying Lin; Zhong-Sheng Xia; Yu-Hong Yuan; Qi-Kui Chen
Journal:  Pathol Oncol Res       Date:  2014-05-30       Impact factor: 3.201
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.